Select Language:
Shanghai’s Waigaoqiao Free Trade Zone Group, a developer specializing in industrial parks, has launched a new partnership program focused on brain-computer interface (BCI) technology. The initiative aims to transform the core area of the zone into a national hub for innovation in this cutting-edge industry.
The program seeks to unite companies, healthcare providers, and government agencies to develop a collaborative ecosystem that overcomes current challenges in BCI development. Key issues include clinical trial hurdles, cross-border data sharing, and market entry difficulties. This initiative was announced during the recent Waigaoqiao Medical and Health Cooperation Summit.
Early participants in the program include StairMed Technology, based in Shanghai; AciMicro Medical from Guangzhou; and NeuroDome from Xi’an. These startups joined on the first day of the launch.
“The tech sector for brain-computer interfaces is nearing a major breakthrough, transitioning from laboratory research to real-world clinical applications,” stated Zhu Yaopeng, general manager of the zone’s biomedical industry development unit. “Our goal is to foster an industrial cluster that captures the future market opportunities.”
Companies involved in the program will benefit from a comprehensive suite of services, covering everything from research and development to clinical approval processes and product export support. Additionally, the first participating firms will receive rental discounts and targeted industrial policy guidance.
StairMed’s wireless, implantable BCI system has become the first invasive brain chip in China to enter the special review process—often called the “green channel”—by national medical product authorities. This marks a significant step toward commercializing the technology, explained Assistant General Manager Chen Yaoxu.
Trial results suggest StairMed’s BCI system can help patients with motor impairments regain some independence. Chen emphasized that China’s invasive BCI technology has shifted from experimental stages to critical verification and practical application phases.
Because BCI development relies heavily on the integration of medicine, science, engineering, and international R&D efforts, Zhu highlighted that the free trade zone’s advantages in facilitating cross-border data exchange and talent mobility can accelerate industry growth.




